SK Capital Partners, a private investment firm focussed on the speciality materials, chemicals and pharmaceuticals sectors, has closed SK Capital Partners Fund V with total committed capital of approximately USD2.1 billion.
Fund V includes a separate overage fund that will enable the firm to provide greater speed and certainty to sellers when it pursues larger transactions.
SK Capital Partners Fund V is the firm’s largest fund to date, eclipsing its USD500 million fund raised in 2011 and its USD1 billion predecessor fund raised in 2014. SK Capital currently has over USD4 billion of assets under management.
SK received strong support from a diverse network of investors, including public pension funds, insurance companies, fund-of-funds, endowments, sovereign wealth funds, foundations and family offices.
“We are pleased by the tremendous demand for Fund V. Both the quality and diversity of our limited partners is indicative of their broad support for SK Capital’s disciplined strategy and strong team that incorporates both deep industry experience and diverse operating skill sets to deliver our targeted returns,” says Barry Siadat, Co-Founder and Managing Director of SK Capital Partners.
“We are grateful to our longtime limited partners for their continuing support and are delighted to welcome a number of new institutional investors to the SK Capital family,” says Jamshid Keynejad, Co-Founder and Managing Director of SK Capital Partners.
In October 2018, the firm made its initial investment from SK Capital Partners Fund V as part of its acquisition of SI Group.
Kirkland & Ellis LLP served as legal advisor and UBS served as placement agent to SK Capital.
